Incyte to Slash 400 Jobs, Jettisons Custom Genomics Platform | GenomeWeb

SAN DIEGO, Oct. 25 – Incyte Genomics on Thursday announced it will jettison its custom genomics program and layoff roughly 400 employees as it restructures its business.

The discontinuation of the custom genomics product lines will lead Incyte to close its facilities in Fremont, Calif., and St. Louis, the company said. Details of the schedule for the shutdown were not disclosed.

The company also announced it was considering ending its internal therapeutic SNP discovery program, which is conducted in Cambridge, England, by the end of the year. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."